img

Global Swine Inactive Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Inactive Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Swine Inactive Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Inactive Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Breeding Farm and Veterinary Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Swine Inactive Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Swine Inactive Vaccine key manufacturers include Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology and Shenlian Biomedical, etc. Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN are top 3 players and held % sales share in total in 2022.
Swine Inactive Vaccine can be divided into Mycoplasma Hyopneumoniae Bacterin Vaccine, Haemophilus Parasuis Vaccine, Porcine Circovirus Type 2 Vaccine and Others, etc. Mycoplasma Hyopneumoniae Bacterin Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Swine Inactive Vaccine is widely used in various fields, such as Breeding Farm and Veterinary Clinic, etc. Breeding Farm provides greatest supports to the Swine Inactive Vaccine industry development. In 2022, global % sales of Swine Inactive Vaccine went into Breeding Farm filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Inactive Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Harbin Pharmaceutical Group Bio-vaccine
DHN
Shenzhen BIOCBD Biotechnology
Jinyu Biotechnology
Zhongmu Industry
Qindao Lijian Bio-Tech
Wuhan Keqian Biology
Shenlian Biomedical
Segment by Type
Mycoplasma Hyopneumoniae Bacterin Vaccine
Haemophilus Parasuis Vaccine
Porcine Circovirus Type 2 Vaccine
Others

Segment by Application


Breeding Farm
Veterinary Clinic

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swine Inactive Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Inactive Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Inactive Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Swine Inactive Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Inactive Vaccine introduction, etc. Swine Inactive Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Swine Inactive Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Swine Inactive Vaccine Market Overview
1.1 Swine Inactive Vaccine Product Overview
1.2 Swine Inactive Vaccine Market Segment by Type
1.2.1 Mycoplasma Hyopneumoniae Bacterin Vaccine
1.2.2 Haemophilus Parasuis Vaccine
1.2.3 Porcine Circovirus Type 2 Vaccine
1.2.4 Others
1.3 Global Swine Inactive Vaccine Market Size by Type
1.3.1 Global Swine Inactive Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Swine Inactive Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Swine Inactive Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Inactive Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Swine Inactive Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Swine Inactive Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Swine Inactive Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Swine Inactive Vaccine Sales Breakdown by Type (2024-2024)
2 Global Swine Inactive Vaccine Market Competition by Company
2.1 Global Top Players by Swine Inactive Vaccine Sales (2024-2024)
2.2 Global Top Players by Swine Inactive Vaccine Revenue (2024-2024)
2.3 Global Top Players by Swine Inactive Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Swine Inactive Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Inactive Vaccine Market Competitive Situation and Trends
2.5.1 Swine Inactive Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Inactive Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Inactive Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Inactive Vaccine Market
2.8 Key Manufacturers Swine Inactive Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Swine Inactive Vaccine Status and Outlook by Region
3.1 Global Swine Inactive Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Swine Inactive Vaccine Historic Market Size by Region
3.2.1 Global Swine Inactive Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Swine Inactive Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Swine Inactive Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Swine Inactive Vaccine Forecasted Market Size by Region
3.3.1 Global Swine Inactive Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Swine Inactive Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Swine Inactive Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Swine Inactive Vaccine by Application
4.1 Swine Inactive Vaccine Market Segment by Application
4.1.1 Breeding Farm
4.1.2 Veterinary Clinic
4.2 Global Swine Inactive Vaccine Market Size by Application
4.2.1 Global Swine Inactive Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Swine Inactive Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Swine Inactive Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Inactive Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Swine Inactive Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Swine Inactive Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Swine Inactive Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Swine Inactive Vaccine Sales Breakdown by Application (2024-2024)
5 North America Swine Inactive Vaccine by Country
5.1 North America Swine Inactive Vaccine Historic Market Size by Country
5.1.1 North America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Swine Inactive Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Swine Inactive Vaccine Sales in Value by Country (2024-2024)
5.2 North America Swine Inactive Vaccine Forecasted Market Size by Country
5.2.1 North America Swine Inactive Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Swine Inactive Vaccine Sales in Value by Country (2024-2034)
6 Europe Swine Inactive Vaccine by Country
6.1 Europe Swine Inactive Vaccine Historic Market Size by Country
6.1.1 Europe Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Swine Inactive Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Swine Inactive Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Swine Inactive Vaccine Forecasted Market Size by Country
6.2.1 Europe Swine Inactive Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Swine Inactive Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Swine Inactive Vaccine by Region
7.1 Asia-Pacific Swine Inactive Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Swine Inactive Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Swine Inactive Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Swine Inactive Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Inactive Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Swine Inactive Vaccine Sales in Value by Region (2024-2034)
8 Latin America Swine Inactive Vaccine by Country
8.1 Latin America Swine Inactive Vaccine Historic Market Size by Country
8.1.1 Latin America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Swine Inactive Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Swine Inactive Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Swine Inactive Vaccine Forecasted Market Size by Country
8.2.1 Latin America Swine Inactive Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Swine Inactive Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Swine Inactive Vaccine by Country
9.1 Middle East and Africa Swine Inactive Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Swine Inactive Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Swine Inactive Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Swine Inactive Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Inactive Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Swine Inactive Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information
10.1.2 Boehringer Ingelheim Introduction and Business Overview
10.1.3 Boehringer Ingelheim Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Boehringer Ingelheim Swine Inactive Vaccine Products Offered
10.1.5 Boehringer Ingelheim Recent Development
10.2 Harbin Pharmaceutical Group Bio-vaccine
10.2.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
10.2.2 Harbin Pharmaceutical Group Bio-vaccine Introduction and Business Overview
10.2.3 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Products Offered
10.2.5 Harbin Pharmaceutical Group Bio-vaccine Recent Development
10.3 DHN
10.3.1 DHN Company Information
10.3.2 DHN Introduction and Business Overview
10.3.3 DHN Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 DHN Swine Inactive Vaccine Products Offered
10.3.5 DHN Recent Development
10.4 Shenzhen BIOCBD Biotechnology
10.4.1 Shenzhen BIOCBD Biotechnology Company Information
10.4.2 Shenzhen BIOCBD Biotechnology Introduction and Business Overview
10.4.3 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Products Offered
10.4.5 Shenzhen BIOCBD Biotechnology Recent Development
10.5 Jinyu Biotechnology
10.5.1 Jinyu Biotechnology Company Information
10.5.2 Jinyu Biotechnology Introduction and Business Overview
10.5.3 Jinyu Biotechnology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Jinyu Biotechnology Swine Inactive Vaccine Products Offered
10.5.5 Jinyu Biotechnology Recent Development
10.6 Zhongmu Industry
10.6.1 Zhongmu Industry Company Information
10.6.2 Zhongmu Industry Introduction and Business Overview
10.6.3 Zhongmu Industry Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Zhongmu Industry Swine Inactive Vaccine Products Offered
10.6.5 Zhongmu Industry Recent Development
10.7 Qindao Lijian Bio-Tech
10.7.1 Qindao Lijian Bio-Tech Company Information
10.7.2 Qindao Lijian Bio-Tech Introduction and Business Overview
10.7.3 Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Qindao Lijian Bio-Tech Swine Inactive Vaccine Products Offered
10.7.5 Qindao Lijian Bio-Tech Recent Development
10.8 Wuhan Keqian Biology
10.8.1 Wuhan Keqian Biology Company Information
10.8.2 Wuhan Keqian Biology Introduction and Business Overview
10.8.3 Wuhan Keqian Biology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Wuhan Keqian Biology Swine Inactive Vaccine Products Offered
10.8.5 Wuhan Keqian Biology Recent Development
10.9 Shenlian Biomedical
10.9.1 Shenlian Biomedical Company Information
10.9.2 Shenlian Biomedical Introduction and Business Overview
10.9.3 Shenlian Biomedical Swine Inactive Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Shenlian Biomedical Swine Inactive Vaccine Products Offered
10.9.5 Shenlian Biomedical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Inactive Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Inactive Vaccine Industrial Chain Analysis
11.4 Swine Inactive Vaccine Market Dynamics
11.4.1 Swine Inactive Vaccine Industry Trends
11.4.2 Swine Inactive Vaccine Market Drivers
11.4.3 Swine Inactive Vaccine Market Challenges
11.4.4 Swine Inactive Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Inactive Vaccine Distributors
12.3 Swine Inactive Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Mycoplasma Hyopneumoniae Bacterin Vaccine
Table 2. Major Company of Haemophilus Parasuis Vaccine
Table 3. Major Company of Porcine Circovirus Type 2 Vaccine
Table 4. Major Company of Others
Table 5. Global Swine Inactive Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Swine Inactive Vaccine Sales by Type (2024-2024) & (K Units)
Table 7. Global Swine Inactive Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Swine Inactive Vaccine Sales by Type (2024-2024) & (US& Million)
Table 9. Global Swine Inactive Vaccine Market Share in Value by Type (2024-2024)
Table 10. Global Swine Inactive Vaccine Price by Type (2024-2024) & (USD/Unit)
Table 11. Global Swine Inactive Vaccine Sales by Type (2024-2034) & (K Units)
Table 12. Global Swine Inactive Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Swine Inactive Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Swine Inactive Vaccine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Swine Inactive Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Swine Inactive Vaccine Sales by Type (2024-2024) & (K Units)
Table 17. North America Swine Inactive Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Swine Inactive Vaccine Sales (K Units) by Type (2024-2024)
Table 19. Europe Swine Inactive Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Swine Inactive Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Swine Inactive Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Swine Inactive Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Latin America Swine Inactive Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Swine Inactive Vaccine Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Swine Inactive Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Swine Inactive Vaccine Sales by Company (2024-2024) & (K Units)
Table 27. Global Swine Inactive Vaccine Sales Share by Company (2024-2024)
Table 28. Global Swine Inactive Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Swine Inactive Vaccine Revenue Share by Company (2024-2024)
Table 30. Global Market Swine Inactive Vaccine Price by Company (2024-2024) & (USD/Unit)
Table 31. Global Swine Inactive Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Swine Inactive Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Inactive Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Swine Inactive Vaccine Market
Table 35. Key Manufacturers Swine Inactive Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Swine Inactive Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Swine Inactive Vaccine Sales by Region (2024-2024) & (K Units)
Table 39. Global Swine Inactive Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Swine Inactive Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Swine Inactive Vaccine Sales Market Share in Value by Region (2024-2024)
Table 42. Global Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 43. Global Swine Inactive Vaccine Sales by Region (2024-2034) & (K Units)
Table 44. Global Swine Inactive Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Swine Inactive Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Swine Inactive Vaccine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Swine Inactive Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Swine Inactive Vaccine Sales by Application (2024-2024) & (K Units)
Table 50. Global Swine Inactive Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Swine Inactive Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Swine Inactive Vaccine Sales Market Share in Value by Application (2024-2024)
Table 53. Global Swine Inactive Vaccine Price by Application (2024-2024) & (USD/Unit)
Table 54. Global Swine Inactive Vaccine Sales by Application (2024-2034) & (K Units)
Table 55. Global Swine Inactive Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Swine Inactive Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Swine Inactive Vaccine Sales Market Share in Value by Application (2024-2034)
Table 58. Global Swine Inactive Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Swine Inactive Vaccine Sales by Application (2024-2024) (K Units)
Table 60. North America Swine Inactive Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Swine Inactive Vaccine Sales by Application (2024-2024) (K Units)
Table 62. Europe Swine Inactive Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Swine Inactive Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Swine Inactive Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Swine Inactive Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Latin America Swine Inactive Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Swine Inactive Vaccine Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Swine Inactive Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Swine Inactive Vaccine Sales by Country (2024-2024) & (K Units)
Table 70. North America Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Swine Inactive Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2024)
Table 73. North America Swine Inactive Vaccine Sales by Country (2024-2034) & (K Units)
Table 74. North America Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Swine Inactive Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Swine Inactive Vaccine Sales by Country (2024-2024) & (K Units)
Table 78. Europe Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Swine Inactive Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Swine Inactive Vaccine Sales by Country (2024-2034) & (K Units)
Table 82. Europe Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Swine Inactive Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Swine Inactive Vaccine Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Swine Inactive Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Swine Inactive Vaccine Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Swine Inactive Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Swine Inactive Vaccine Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Swine Inactive Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Swine Inactive Vaccine Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Swine Inactive Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Swine Inactive Vaccine Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Swine Inactive Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Swine Inactive Vaccine Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Swine Inactive Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Value by Country (2024-2034)
Table 109. Boehringer Ingelheim Company Information
Table 110. Boehringer Ingelheim Introduction and Business Overview
Table 111. Boehringer Ingelheim Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 112. Boehringer Ingelheim Swine Inactive Vaccine Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Harbin Pharmaceutical Group Bio-vaccine Company Information
Table 115. Harbin Pharmaceutical Group Bio-vaccine Introduction and Business Overview
Table 116. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 117. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product
Table 118. Harbin Pharmaceutical Group Bio-vaccine Recent Development
Table 119. DHN Company Information
Table 120. DHN Introduction and Business Overview
Table 121. DHN Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 122. DHN Swine Inactive Vaccine Product
Table 123. DHN Recent Development
Table 124. Shenzhen BIOCBD Biotechnology Company Information
Table 125. Shenzhen BIOCBD Biotechnology Introduction and Business Overview
Table 126. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 127. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product
Table 128. Shenzhen BIOCBD Biotechnology Recent Development
Table 129. Jinyu Biotechnology Company Information
Table 130. Jinyu Biotechnology Introduction and Business Overview
Table 131. Jinyu Biotechnology Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 132. Jinyu Biotechnology Swine Inactive Vaccine Product
Table 133. Jinyu Biotechnology Recent Development
Table 134. Zhongmu Industry Company Information
Table 135. Zhongmu Industry Introduction and Business Overview
Table 136. Zhongmu Industry Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 137. Zhongmu Industry Swine Inactive Vaccine Product
Table 138. Zhongmu Industry Recent Development
Table 139. Qindao Lijian Bio-Tech Company Information
Table 140. Qindao Lijian Bio-Tech Introduction and Business Overview
Table 141. Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 142. Qindao Lijian Bio-Tech Swine Inactive Vaccine Product
Table 143. Qindao Lijian Bio-Tech Recent Development
Table 144. Wuhan Keqian Biology Company Information
Table 145. Wuhan Keqian Biology Introduction and Business Overview
Table 146. Wuhan Keqian Biology Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 147. Wuhan Keqian Biology Swine Inactive Vaccine Product
Table 148. Wuhan Keqian Biology Recent Development
Table 149. Shenlian Biomedical Company Information
Table 150. Shenlian Biomedical Introduction and Business Overview
Table 151. Shenlian Biomedical Swine Inactive Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 152. Shenlian Biomedical Swine Inactive Vaccine Product
Table 153. Shenlian Biomedical Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Swine Inactive Vaccine Market Trends
Table 157. Swine Inactive Vaccine Market Drivers
Table 158. Swine Inactive Vaccine Market Challenges
Table 159. Swine Inactive Vaccine Market Restraints
Table 160. Swine Inactive Vaccine Distributors List
Table 161. Swine Inactive Vaccine Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Inactive Vaccine Product Picture
Figure 2. Global Swine Inactive Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Swine Inactive Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Swine Inactive Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Mycoplasma Hyopneumoniae Bacterin Vaccine
Figure 6. Global Mycoplasma Hyopneumoniae Bacterin Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Haemophilus Parasuis Vaccine
Figure 8. Global Haemophilus Parasuis Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Porcine Circovirus Type 2 Vaccine
Figure 10. Global Porcine Circovirus Type 2 Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Swine Inactive Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Swine Inactive Vaccine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Swine Inactive Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Swine Inactive Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Swine Inactive Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Swine Inactive Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Swine Inactive Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Swine Inactive Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Inactive Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Inactive Vaccine Revenue in 2022
Figure 27. Swine Inactive Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Breeding Farm
Figure 29. Global Breeding Farm Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Veterinary Clinic
Figure 31. Global Veterinary Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Swine Inactive Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Swine Inactive Vaccine Sales Market Share by Application in 2022 & 2034
Figure 34. North America Swine Inactive Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Swine Inactive Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Swine Inactive Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Swine Inactive Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Swine Inactive Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Swine Inactive Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Swine Inactive Vaccine Manufacturing Cost Structure
Figure 45. Swine Inactive Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries